M. Alevizaki et al., High plasma amylin/islet amyloid polypeptide levels in patients with residual medullary thyroid carcinoma after total thyroidectomy, EUR J ENDOC, 145(5), 2001, pp. 585-589
Objective: We have previously reported that amylin/islet amyloid polypeptid
e (IAPP) mRNA is detected in a substantial subset of medullary carcinomas o
f the thyroid (MTCs). The aim of this study was to determine if the amylin/
IAPP gene is expressed as the IAPP peptide in MTC tissues.
Design and Methods: In 10 patients with a histological diagnosis of MTC and
with persisting or recurrent disease (basal calcitonin levels > 250 pg/ml)
, the fasting serum insulin and plasma glucose, IAPP and calcitonin levels
were measured and compared with those of 18 normal control subjects matched
for age and body mass index. IAPP expression was studied by immunohistoche
mistry in MTCs and lymph-node metastasis tissues.
Results: Seven of ten MTC patients had abnormally elevated IAPP levels. Pla
sma IAPP and serum insulin levels were correlated in both patients and cont
rols, but the slope of the regression line was significantly higher for MTC
patients. IAPP staining was detected in four out of 12 random MTC samples
and in two out of five lymph-node metastases, using immunohistochemistry.
Conclusions: These results indicate that MTC cells express IAPP at the pept
ide level and that this raises the peripheral plasma levels. Further studie
s may reveal whether this is a feature of malignant disease.